Digestive Diseases and Sciences

, Volume 58, Issue 2, pp 496–503 | Cite as

Clinical Course of Intestinal Behcet’s Disease During the First Five Years

  • Yoon Suk Jung
  • Jae Hee Cheon
  • Soo Jung Park
  • Sung Pil Hong
  • Tae Il Kim
  • Won Ho Kim
Original Article

Abstract

Background

Little is known about the clinical course of patients with intestinal Behcet’s disease (BD). We aimed to evaluate the clinical course of intestinal BD during the first 5 years after diagnosis, and to identify factors that could predict the 5-year clinical course.

Methods

We reviewed the medical records of 130 intestinal BD patients who were regularly followed-up for at least 5 years at a single tertiary academic medical center between March 1986 and September 2011.

Results

Of the five different clinical course patterns that we observed, persistent remission or mild clinical activity was the most frequent course (56.2 %). The majority of patients (74.6 %) had remission or mild clinical activity at 5 years, and only the minority (16.2 %) had multiple relapses or chronic symptoms. The clinical course of the first year after diagnosis of intestinal BD influenced the clinical course of the following years. Patients in the severe clinical course group were younger, and had a higher ESR, CRP level, and disease activity index for intestinal Behcet’s disease (DAIBD), and lower albumin level at diagnosis than patients in the mild clinical course group. Initial presentation with a high DAIBD was independently associated with a severe clinical course.

Conclusions

The clinical course of intestinal BD during the first 5 years was variable. A substantial proportion of patients went into remission or had a mild clinical activity, while some patients had a severe, debilitating clinical course as time progressed. High disease activity at diagnosis was a negative prognostic predictor.

Keywords

Intestinal Behcet’s disease Clinical course Prognostic factors High disease activity 

Notes

Conflict of interest

None.

References

  1. 1.
    Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341:1284–1291.PubMedCrossRefGoogle Scholar
  2. 2.
    Kobayashi K, Ueno F, Bito S, et al. Development of consensus statements for the diagnosis and management of intestinal Behcet’s disease using a modified Delphi approach. J Gastroenterol. 2007;42:737–745.PubMedCrossRefGoogle Scholar
  3. 3.
    Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behcet’s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104:2492–2499.PubMedCrossRefGoogle Scholar
  4. 4.
    Cheon JH, Celik AF, Kim WH. Behçet’s disease: gastrointestinal involvement. In: Yazici Y, Yazici H, eds. Behçet’s syndrome. New York: Springer; 2010:165–188.CrossRefGoogle Scholar
  5. 5.
    Ebert EC. Gastrointestinal manifestations of Behçet’s disease. Dig Dis Sci. 2009;54:201–207.PubMedCrossRefGoogle Scholar
  6. 6.
    Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T. Intestinal involvement in Behcet’s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981;24:103–106.PubMedCrossRefGoogle Scholar
  7. 7.
    Jung YS, Yoon JY, Lee JH, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease. Inflamm Bowel Dis. 2011;17:1594–1602.PubMedCrossRefGoogle Scholar
  8. 8.
    Penner RM, Madsen KL, Fedorak RN. Postoperative Crohn’s disease. Inflamm Bowel Dis. 2005;11:765–777.PubMedCrossRefGoogle Scholar
  9. 9.
    Cheon JH, Han DS, Park JY, et al. Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet’s disease. Inflamm Bowel Dis. 2011;17:605–613.PubMedCrossRefGoogle Scholar
  10. 10.
    Jung YS, Cheon JH, Hong SP, Kim TI, Kim WH. Clinical outcomes and prognostic factors for thiopurine maintenance therapy in patients with intestinal Behcet’s disease. Inflamm Bowel Dis. 2012;18:750–757.PubMedCrossRefGoogle Scholar
  11. 11.
    Jung YS, Yoon JY, Hong SP, Kim TI, Kim WH, Cheon JH. Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet’s disease. Inflamm Bowel Dis. 2012;18(6):1064–1071.Google Scholar
  12. 12.
    Lee CR, Kim WH, Cho YS, et al. Colonoscopic findings in intestinal Behçet’s disease. Inflamm Bowel Dis. 2001;7:243–249.PubMedCrossRefGoogle Scholar
  13. 13.
    Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431–440.PubMedCrossRefGoogle Scholar
  14. 14.
    Solberg IC, Vatn MH, Hie O, et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–1438.PubMedCrossRefGoogle Scholar
  15. 15.
    Henriksen M, Jahnsen J, Lygren I, et al. Clinical course in Crohn’s disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol. 2007;42:602–610.PubMedCrossRefGoogle Scholar
  16. 16.
    Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543–550.PubMedCrossRefGoogle Scholar
  17. 17.
    Moum B. Medical treatment: does it influence the natural course of inflammatory bowel disease? Eur J Intern Med. 2000;11:197–203.PubMedCrossRefGoogle Scholar
  18. 18.
    Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn’s disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59:1200–1206.PubMedCrossRefGoogle Scholar
  19. 19.
    Choi IJ, Kim JS, Park MJ, et al. Evaluation of prognosis and cumulative operation rate of intestinal Behcet’s disease in comparison with Crohn’s disease. Korean J Gastroenterol. 2000;36:504–514.Google Scholar
  20. 20.
    Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn’s disease patients. Scand J Gastroenterol. 1995;30:699–706.PubMedCrossRefGoogle Scholar
  21. 21.
    Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3–11.PubMedGoogle Scholar
  22. 22.
    Yoon JY, Cheon JH, Park JJ, Hong SP, Kim TI, Kim WH. Clinical outcomes and factors for response prediction after the first course of corticosteroid therapy in patients with active ulcerative colitis. J Gastroenterol Hepatol. 2011;26:1114–1122.PubMedCrossRefGoogle Scholar
  23. 23.
    Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Yoon Suk Jung
    • 1
    • 2
  • Jae Hee Cheon
    • 1
  • Soo Jung Park
    • 1
  • Sung Pil Hong
    • 1
  • Tae Il Kim
    • 1
  • Won Ho Kim
    • 1
  1. 1.Division of Gastroenterology, Department of Internal MedicineYonsei University College of MedicineSeodaemun-gu, SeoulKorea
  2. 2.Department of Internal MedicineKangbuk Samsung Hospital, Sungkyunkwan University School of MedicineSeoulKorea

Personalised recommendations